Join MitoAction and Dr. Richard Boles from Children's Hospital Los Angeles and Courtagen Life Sciences, Inc to discuss the following questions: What is genomic sequencing and how does it change testing for mitochondrial disorders?, Is NextGen testing appropriate for all people with suspected mitochondrial disease?, How can DNA sequencing change information available about family inheritance of mitochondrial diseases?, Do advances in genomic sequencing impact treatment options for Mito patients?